His primary areas of investigation include Hepatitis C, Internal medicine, Hepatitis C virus, Incidence and Immunology. His Hepatitis C study combines topics from a wide range of disciplines, such as Transmission, Substance abuse, Syringe and Environmental health. The Meta-analysis, Relative risk and Odds ratio research Peter Vickerman does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Opiate Substitution Treatment, therefore creating a link between diverse domains of science.
The concepts of his Hepatitis C virus study are interwoven with issues in Liver disease and Hepatology. His Immunology research is multidisciplinary, relying on both Quality-adjusted life year and Sexual transmission. Peter Vickerman has included themes like Acquired immunodeficiency syndrome and Intensive care medicine in his Psychological intervention study.
Peter Vickerman mostly deals with Environmental health, Hepatitis C, Psychological intervention, Acquired immunodeficiency syndrome and Incidence. He has researched Environmental health in several fields, including Harm reduction, Public health, Drug and Needle sharing. His work deals with themes such as Transmission, Substance abuse, Emergency medicine and Hepatitis C virus, which intersect with Hepatitis C.
His research in Psychological intervention intersects with topics in Intervention, Surgery, Syringe and Developing country. His studies deal with areas such as Gerontology and Immunology as well as Acquired immunodeficiency syndrome. Incidence connects with themes related to Epidemiology in his study.
Peter Vickerman spends much of his time researching Hepatitis C, Incidence, Environmental health, Psychological intervention and Hepatitis C virus. Hepatitis C is a subfield of Internal medicine that Peter Vickerman tackles. His Incidence study integrates concerns from other disciplines, such as Young adult, Epidemiology and Pre-exposure prophylaxis.
As part of the same scientific family, Peter Vickerman usually focuses on Environmental health, concentrating on Transmission and intersecting with Attributable risk. His work carried out in the field of Psychological intervention brings together such families of science as Men who have sex with men, Syringe, Intervention, Relative risk and Hcv transmission. His biological study spans a wide range of topics, including Drug and Risk factor.
Peter Vickerman mainly focuses on Hepatitis C, Environmental health, Incidence, Psychological intervention and Hepatitis C virus. His study in Hepatitis C is interdisciplinary in nature, drawing from both Syringe, Emergency medicine, Hcv transmission, Hcv treatment and Cohort. His Environmental health research is multidisciplinary, incorporating perspectives in Global health, Public health, Drug and Meta-analysis.
His Incidence study combines topics in areas such as Transmission, Young adult and Pre-exposure prophylaxis. His Psychological intervention research includes themes of Treatment as prevention, Epidemiology and Men who have sex with men. His Hepatitis C virus study incorporates themes from Internal medicine and Risk factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
Louisa Degenhardt;Amy Peacock;Samantha Colledge;Janni Leung.
The Lancet Global Health (2017)
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
Lucy Platt;Philippa Easterbrook;Erin Gower;Bethan McDonald.
Lancet Infectious Diseases (2016)
Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals
Natasha K. Martin;Peter Vickerman;Jason Grebely;Margaret Hellard.
Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed
Louisa Degenhardt;Bradley Mathers;Peter Vickerman;Peter Vickerman;Tim Rhodes;Tim Rhodes.
The Lancet (2010)
Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012
Katharine J Looker;Amalia S Magaret;Margaret T May;Katherine Mary Elizabeth Turner.
PLOS ONE (2015)
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.
Georgina J MacArthur;Silvia Minozzi;Natasha Martin;Natasha Martin;Peter Vickerman;Peter Vickerman.
Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.
Katharine J Looker;Amalia S Magaret;Katherine Mary Elizabeth Turner;Peter Vickerman.
PLOS ONE (2015)
Public health and international drug policy
Joanne Csete;Adeeba Kamarulzaman;Michel Kazatchkine;Frederick Altice.
The Lancet (2016)
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
Katy Turner;Sharon Hutchinson;Peter Vickerman;Vivian Hope;Vivian Hope.
Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
Natasha K. Martin;Natasha K. Martin;Matthew Hickman;Sharon J. Hutchinson;Sharon J. Hutchinson;David J. Goldberg.
Clinical Infectious Diseases (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: